
Parkinson's Disease and Parkinsonism - Part 6
In part 6 of our 9-part series on Parkinson's disease, Dr. Alberto Espay discusses dystonias. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
16 Marras 20223min

Parkinson's Disease and Parkinsonism - Part 5
In part 5 of our 9-part series, Dr. Alberto Espay continues discussing managing patients' symptoms while on Levodopa. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more informatio...
15 Marras 20223min

Parkinson's Disease and Parkinsonism - Part 4
In part 4 of our 9-part series, Dr. Alberto Espay discusses managing patients' symptoms while on Levodopa. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
14 Marras 20223min

CGRP and Role of Sex Hormones
Dr. Lars Edvinsson discusses CGRP and migraine therapies. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
11 Marras 20221min

Pre-Hospital Evaluation of Acute Stroke: EMS vs Telemed
Dr. Imogene Mary Scott discusses her paper, "Pre-Hospital Telestroke vs Paramedic Scores to Accurately Identify Stroke Reperfusion Candidates: A Cluster Randomised Controlled Trial". Show references: ...
10 Marras 20222min

Parkinson's Disease and Parkinsonism - Part 3
In part 3 of our 9-part series, Dr. Alberto Espay discusses the use of extended-release drugs for the management of Parkinson's Disease. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com...
9 Marras 20223min

Parkinson's Disease and Parkinsonism - Part 2
In part 2 of a 9-part series, Dr. Alberto Espay continues the discussion on the diagnosis of Parkinson's Disease using Levodopa. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for mor...
8 Marras 20224min

Parkinson's Disease and Parkinsonism - Part 1
In part 1 of a 9-part series, Dr. Alberto Espay discusses the diagnosis of Parkinson's Disease using Levodopa. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
7 Marras 20224min



















